维普中文期刊产品整合服务
261篇 您的检索式:作者名="TSIMIKAS S"
    题名 作者 年代 出处 被引量
1Drug-eluting stents and late adverse clinical outcomes lessons learned,lessons awaited显示文摘Tsimikas S 2006J Am Coll Cardiol2006,47,10:1
2LDL isolated from greek subjects on a typical diet or from American sub- jects on an oleate-supplemented diet induces lessmonocyte chemotaxis and adhesion when exposed to oxidative stress 显示文摘Tsimikas S Tsimikas A Alexopoules S eta/ 1999Arter/oscler Thromb Vasc Biol1999,19,1:1
3Elevated plasma fibrinogen and diabetes mellitus are associated with lower inhibition of platelet reactivity with clopidogrel显示文摘Ang L Palakodeti V Khalid A Tsimikas S Idrees Z Tran P 2008J Am Coll Cardiol2008,52,:1
4C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients显示文摘Tsimikas S Willerson JT Ridker PM 2006J Am Coll Cardiol2006,47,8:1
5Relationship of oxidized phospholipids on apolipoprotein B100 particles to race/ethnicity, apolipoprotein (a) isoform size, and cardiovascular risk factors: results from the Dallas Heart Study显示文摘Tsimikas S Clopton P Brilakis ES 2009Circulation2009,119,13:1
6Candidate biomarkers for the detection of coronary plaque destabilization and rupture显示文摘Prasad A Tsimikas S 2008Curt Atheroscler Rep2008,10,4:1
7New therapeutic targets for calcific aortic valve stenosis:the lipoprotein(a)-lipoprotein-associated phospholipase A2-oxidized phospholipid axis显示文摘HUNG M Y WITZTUM J L TSIMIKAS S 2014J Am Coll Cardiol2014,63,:1
8Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study显示文摘Tsimikas S Kiechl S Willeit J 2006J Am Coll Cardiol2006,47,11:1
9Ill vivo markers of oxidative stress and therapeutic inter- ventions 显示文摘Tsimikas S 2008The American journal of cardiology2008,101,10:1
10Noninvasive imaging of oxidized lowdensity lipoprotein in atherosclerotic plaques with tagged oxidationspecific antibodies显示文摘Tsimikas S 2002Am J Cardiol2002,90,10:1
11Statin-associated pleiotropy:possible beneficial elects beyond cholesteml reduction显示文摘Ito MK Talbert RI Tsimikas S 2006J Pharmacothempy2006,26,7:1
12Measuring circulating oxidized low density lipoprotein to evaluate coronary risk显示文摘Tsimikas S Witztum JL 2001Circulation2001,103,15:1
13Statin-associated pleiotropy:possible beneficial effects beyond cholesterol reduction显示文摘Ito MK Talbert RL Tsimikas S 2006Pharmacotherapy2006,26,:1
14Oxidized low-density lipoprotein biomarkers in atherosclerosis显示文摘Tsimikas S 2006Curr Atheroscler Rep2006,8,1:1
15Temporal increases in plasma markers of oxidized low - density lipoprotein strongly reflect the presence of acute coronary syndromes 显示文摘Tsimikas S Bergmark C Beyer RW 2003J Am Coll Cardiol2003,41,3:1
16Statin-associated pleiotropy:possible beneficial effects beyond cholesterol reduction显示文摘Ito MK Talbert RL Tsimikas S 2006Pharmacotherapy2006,26,2:1
17Plasma levels of advanced glycation end products are related to the clinical presentation and angiographic severity of symptomatic lower extremity peripheral ar- terial disease 显示文摘Prasad A Lane JR Tsimikas S 2016Int J Angio12016,25,1:1
18Statin - associated pleiotropy : possible beneficial effects beyond cholesterol reduction 显示文摘Ito MK Talbert RL Tsimikas S 2006Pharmacotherapy2006,26,72:1
19Statin-associated pleiotropy: possible beneficial effects beyond cholesterol reduction 显示文摘ITO M K TALBERT R L TSIMIKAS S 2006Pharmacotherapy2006,26,72:1
20In vivo markers of oxidative stress and therapeutic interventions显示文摘Tsimikas S 2008Am J Cardiol2008,101,10:1
返回顶部 每页显示:
共14页 首页 上一页 第1页 下一页 末页 /14 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费